Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TALIMOGENE LAHERPAREPVEC vs TAPINAROF: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TALIMOGENE LAHERPAREPVEC vs TAPINAROF: Safety Overview

Metric TALIMOGENE LAHERPAREPVEC TAPINAROF
Total FAERS Reports 1,475 1,387
Deaths Reported 164 2
Death Rate 11.1% 0.1%
Hospitalizations 286 25
Average Patient Age 66.7 yrs 53.0 yrs
% Female Patients 48.3% 51.7%
FDA Approval Date N/A May 23, 2022
Manufacturer Amgen Inc Organon LLC
Route INTRALESIONAL TOPICAL
Marketing Status N/A Prescription